SENS
Senseonics Holdings, Inc.NASDAQHealthcare$6.90+3.76%ClosedMarket Cap: $288.2M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
4.57
P/S
7.57
EV/EBITDA
-5.24
DCF Value
$-23.06
FCF Yield
-23.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
45.0%
Operating Margin
-184.9%
Net Margin
-189.9%
ROE
-104.2%
ROA
-55.5%
ROIC
-66.6%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $14.3M | 53.8% | $-20.9M | $-20.8M | $-0.50 | — |
| FY 2025 | $35.3M | 44.7% | $-68.3M | $-69.1M | $-1.66 | — |
| Q3 2025 | $8.1M | 42.8% | $-19.6M | $-19.5M | $-0.43 | — |
| Q2 2025 | $8.3M | 47.6% | $-14.3M | $-15.5M | $-0.52 | — |
| Q1 2025 | $6.3M | 24.1% | $-13.5M | $-14.3M | $-0.40 | — |
| Q4 2024 | $8.3M | 47.6% | $-14.3M | $-15.5M | $-0.46 | — |
| FY 2024 | $22.5M | 2.4% | $-74.8M | $-78.6M | $-2.50 | — |
| Q3 2024 | $4.3M | -95.0% | $-22.8M | $-24.0M | $-0.77 | — |
| Q2 2024 | $4.9M | 6.1% | $-19.5M | $-20.3M | $-0.66 | — |
| Q1 2024 | $5.0M | 6.6% | $-18.2M | $-18.9M | $-0.61 | — |
| Q4 2023 | $8.0M | 13.6% | $-17.0M | $-17.2M | $-0.65 | — |
| FY 2023 | $22.4M | 13.8% | $-75.6M | $-60.4M | $-2.20 | — |